Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
V129763-10mg | 10mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $145.90 | |
V129763-50mg | 50mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $628.90 | |
V129763-250mg | 250mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $2,830.90 |
High affinity 5-HT3antagonist
Synonyms | 155584-74-0 | 2-chloro-3-(4-methylpiperazin-1-yl)quinoxaline | VUF 10166 | Quinoxaline, 2-chloro-3-(4-methyl-1-piperazinyl)- | CHEMBL261010 | VUF10166 | VUF10166;VUF-10166 | 2-Chloro-3-(4-methyl-1-piperazinyl)quinoxaline | SCHEMBL404203 | DTXSID60640663 | HMS3651F21 | HMS3884N |
---|---|
Specifications & Purity | ≥99% |
Biochemical and Physiological Mechanisms | High affinity 5-HT3receptor antagonist (IC50values are 0.04 and 22 nM for human 5HT3Aand 5-HT3ABreceptors respectively). Exhibits partial agonist activity at 5-HT3Areceptors at higher concentrations (EC50= 5.2μM). Also histamine H4receptor antagonist (pKi |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Note | 卖完停产,不再备货 |
Product Description | VUF10166 is a novel, potent and competitive antagonist for 5-HT3A receptor with Ki of 0.04 nM, its affinity at 5-HT3AB receptor is significantly lower. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
IUPAC Name | 2-chloro-3-(4-methylpiperazin-1-yl)quinoxaline |
---|---|
INCHI | InChI=1S/C13H15ClN4/c1-17-6-8-18(9-7-17)13-12(14)15-10-4-2-3-5-11(10)16-13/h2-5H,6-9H2,1H3 |
InChi Key | FFXVTQDGTKEXHF-UHFFFAOYSA-N |
Canonical SMILES | CN1CCN(CC1)C2=NC3=CC=CC=C3N=C2Cl |
Isomeric SMILES | CN1CCN(CC1)C2=NC3=CC=CC=C3N=C2Cl |
PubChem CID | 24278976 |
Molecular Weight | 262.74 |
Enter Lot Number to search for COA:
Solubility | Solvent:DMSO, Max Conc. mg/mL: 26.27, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 26.27, Max Conc. mM: 100 |
---|